Kidney disease is associated with in-hospital death of patients with COVID-19 {#sec1}
=============================================================================

The pulmonary manifestations of Novel Coronavirus (COVID-19) have been the focus of attention in the pandemic that is upon us. However, other organs may be affected. Cheng *et al.* from Wuhan, the epicenter of the outbreak, have documented their experience with COVID-19 and the kidney in over 700 patients. Not unexpectedly, many of these patients developed acute kidney injury (AKI), and AKI was associated with a higher risk for in-hospital mortality, as was pre-existing chronic kidney disease. While AKI is not a surprising finding in critically ill patients, the investigators found that upon admission to the hospital for COVID-19 infection, 44% of patients had proteinuria and 27% had hematuria. These findings raise the question of whether the virus has a direct effect on the kidney and if it may cause AKI in addition to the usual suspects in sick patients. **See** **page 829**

A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients {#sec2}
=======================================================================================================================

Understanding the molecular mechanisms of phospholipase A2 receptor 1 (PLA2R)--associated membranous nephropathy (MN), the dominant form of MN seen in patients, has been hampered by not having an experimental model for investigation. Meyer-Schwesinger *et al.* have taken a major step to solve this problem by generating a mouse that expresses murine PLA2R1 in its podocytes. Administration of rabbit anti-murine PLA2R1 antibodies to these mice resulted in the development of proteinuria, subepithelial immune complexes, and glomerular complement deposition, recapitulating human MN. The degree of proteinuria was dependent on the amount of anti-PLA2R antibodies given. Although this model is passive and uses a heterologous antibody, it represents a critical advance for the investigation of the pathogenesis of MN. **See** **page 913**

The spectrum of kidney biopsy findings in HIV-infected patients in the modern era {#sec3}
=================================================================================

Because active retroviral therapy (ART) has changed the natural history of HIV infection, a recent Kidney Disease: Improving Global Outcomes report recommended reevaluation of kidney pathology in HIV, specifically discouraging the term *HIV immune complex disease of the kidney* (*HIVICK*) for immune complex glomerulonephritis (ICGN). Kudose *et al.* therefore reported on the kidney biopsy findings of over 400 HIV-infected patients. The frequency of HIV-associated nephropathy was much lower than in the pre-ART era and was mainly restricted to patients not on ART. Diabetic kidney disease was found in a significant proportion of patients, consistent with aging and lifestyle comorbidities in a population with increased survival. Most cases of ICGN could be classified into a known diagnostic category that was not HIV-related. The 2 most common ICGNs seen were IgA nephropathy and membranous nephropathy, about one-half of which were anti-PLA2R antibody positive. A minority of ICGN were unexplained and possibly due to HIV. These data demonstrate the importance of the kidney biopsy in HIV patients with kidney abnormalities. **See** **page 1006**

Kidney residency of VISTA-positive macrophages accelerates repair from ischemic injury {#sec4}
======================================================================================

Park *et al.* examined the role of kidney tissue resident macrophages in the response to ischemia reperfusion injury (IRI). They demonstrated that in the absence of resident and infiltrating macrophages the kidney was protected from IRI. But, in the absence of resident macrophages, recovery from IRI was delayed, suggesting resident macrophages serve a repair function. Further analysis demonstrated that kidney resident macrophages constitutively express the V-domain Ig suppressor of T cell activation (VISTA), an inhibitory immune checkpoint molecule. They found that VISTA was involved in the clearance of apoptotic cells and in attenuating proliferation and interferon-γ production by infiltrating T cells. These mechanisms were felt to be important in accelerating repair after IRI. Finally, the investigators showed that VISTA-positive resident macrophages are also present in human kidneys, raising the possibility that they also serve a protective function in human renal injury. **See** **page 980**

Five-year kidney outcomes of bariatric surgery differ in severely obese adolescents and adults with and without type 2 diabetes {#sec5}
===============================================================================================================================

Obesity is a significant problem in adolescence that often extends into adulthood. Bariatric surgery may mitigate adverse kidney outcomes related to obesity, but whether surgery should be done early (during adolescence) is unclear. Bjornstad *et al.* examined this question in severely obese teenagers and severely obese adults who were obese since adolescence. Unexpectedly, the adolescents had a 2-fold higher prevalence of albuminuria than the adults did, despite the adults having a longer duration of obesity. The main positive finding was a more rapid decline in albuminuria in adolescent patients with type 2 diabetes after bariatric surgery than in adult patients with type 2 diabetes. In the absence of type 2 diabetes, bariatric surgery did not improve albuminuria in either group. The results of bariatric surgery on estimated glomerular filtration rate and hyperfiltration did not differ between adolescents and adults. While early bariatric surgery may offer an advantage to obese teenagers with type 2 diabetes, its benefits must be weighed against surgical adverse events. **See** **page 995**
